TATA box-based analysis reveals activation of growth programs in bladder cancer cells despite ferroptosis activation
Mauricio Fernández‐GonzáleziD, Ricardo ArmiséniD, Mario Ignacio FernándeziD
Abstract
A poorly studied mechanism suggests that growth is characterized by the expression of TATA-less genes under favorable conditions, while stress induces TATA-containing genes involved in stress responses. The role of this mechanism in cancer remains unclear. This study analyzes the presence of TATA boxes in gene expression data from bladder cancer (BC) cells undergoing ferroptosis (siUSP52 cells), a form of programmed cell death. We hypothesize that growth-related genes (TATA-less) are underrepresented in siUSP52 cells. We found a high prevalence of TATA-less genes in siUSP52 cells (62 of 90 differentially expressed), suggesting that BC promotes growth despite ferroptosis activation.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systematic analysis of aberrances of ferroptosis reveals its potential functional roles in cancer
- Systematic Evaluation Defines the Limits of Ferroptosis in Cancer Therapy
Kenji Mark Fujihara, Azmi Aziz, … Richard Possemato·bioRxiv·Mar 14, 2026
- Loss of Ferroptosis-suppressors Accelerates Breast Cancer Recurrence by Promoting Dormancy Exit
Emily K. Shea, Matthew Lawrence-Paul, … Lewis A. Chodosh·bioRxiv·Oct 28, 2026
- PERK arm of UPR selectively regulates ferroptosis in colon cancer cells by modulating the expression of SLC7A11 (System Xc-)
K. K. Saini, P. Chaturvedi, … D. Datta·bioRxiv·Mar 28, 2023
- Epstein-Barr virus latency programs dynamically sensitize B-cells to ferroptosis
E. M. Burton, J. Voyer, B. E. Gewurz·bioRxiv·Feb 21, 2022
- Identification and validation of a ferroptosis-related genes based prognostic signature for prostate cancer